NasdaqGM - Delayed Quote USD
Keros Therapeutics, Inc. (KROS)
At close: October 22 at 4:00 PM EDT
After hours: October 22 at 4:18 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-143,802.00
-124,508.00
-70,062.00
-62,148.00
-36,894.00
--
Investing Cash Flow
-2,347.00
-2,464.00
-1,241.00
-1,024.00
-294.00
--
Financing Cash Flow
229,871.00
178,956.00
120,309.00
28,550.00
296,044.00
--
End Cash Position
407,075.00
332,359.00
280,375.00
231,369.00
265,991.00
--
Income Tax Paid Supplemental Data
--
--
--
--
--
256.00
Capital Expenditure
-2,347.00
-2,464.00
-1,241.00
-1,024.00
-294.00
--
Issuance of Capital Stock
220,486.00
175,825.00
119,578.00
28,171.00
299,202.00
--
Free Cash Flow
-146,149.00
-126,972.00
-71,303.00
-63,172.00
-37,188.00
--
12/31/2019 - 4/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RYTM Rhythm Pharmaceuticals, Inc.
49.13
-2.11%
SLN Silence Therapeutics plc
18.00
+0.17%
MRUS Merus N.V.
53.19
+3.08%
AGIO Agios Pharmaceuticals, Inc.
45.38
-0.61%
IDYA IDEAYA Biosciences, Inc.
30.22
-2.14%
PMVP PMV Pharmaceuticals, Inc.
1.7100
+7.55%
LXEO Lexeo Therapeutics, Inc.
10.07
-4.28%
MLTX MoonLake Immunotherapeutics
48.00
-2.08%
SYRE Spyre Therapeutics, Inc.
34.15
+5.30%
KYMR Kymera Therapeutics, Inc.
48.37
+3.89%